RxDoctor Payments Data

C Bevill, MD

Family Medicine · Cartersville, GANPI 1619993102

Payments from drug & device makers

$11,306in general payments, 2019–2025

Across 682 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$1K
  • AbbVie$1K
  • Amgen$975
  • AstraZeneca$798
  • Pfizer$790
  • plus $5K from 50 others

What the payments were for

  • Food & beverage$11,17199%
  • Education$1351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk77$1,329
Lilly USA, LLC72$1,073
AbbVie(2 entities)98$1,029
Amgen54$975
AstraZeneca41$798
Pfizer47$790
Sanofi-aventis U.S. LLC22$364
Astellas Pharma US Inc17$293
GSK18$279
Boehringer Ingelheim17$278
Novartis12$225
Bayer9$217
Abbott11$203
Merck12$199
Johnson & Johnson11$174
Antares Pharma, Inc.9$166
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$166
Axsome Therapeutics, Inc.7$155
Sumitomo Pharma America, Inc.9$146
Takeda Pharmaceuticals U.S.A., Inc.7$139
Exact Sciences7$132
Esperion Therapeutics, Inc.8$130
Supernus Pharmaceuticals, Inc.6$130
Biohaven Pharmaceutical Holding Company Ltd.5$126
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$125
Biohaven Pharmaceuticals, Inc.6$120
Radius Health, Inc.6$115
Almatica Pharma LLC7$114
Eisai Inc.8$111
Impel Pharmaceuticals Inc.5$97
Amneal Pharmaceuticals LLC5$95
Amarin Pharma, Inc.6$90
Corcept Therapeutics3$79
Idorsia Pharmaceuticals US Inc4$69
Dexcom, Inc.2$60
Phathom Pharmaceuticals, Inc.3$57
Lundbeck LLC2$56
Currax Pharmaceuticals LLC4$55
Jazz Pharmaceuticals Inc.2$52
Otsuka America Pharmaceutical, Inc.2$49
Teva Pharmaceuticals USA, Inc.3$47
Avanir Pharmaceuticals, Inc.3$40
Medtronic(2 entities)2$36
Endo Pharmaceuticals Inc.2$35
Kowa Pharmaceuticals America, Inc.2$32
Sanofi Pasteur Inc.2$32
Nalpropion Pharmaceuticals LLC2$30
Upsher-smith Laboratories LLC2$28
Aytu Biopharma, Inc.2$27
Saluda Medical Americas, Inc.1$26
Shield Therapeutics Inc1$23
Globus Medical1$21
Tris Pharma Inc1$20
Shire North American Group Inc1$17
Vivus LLC1$17
Ironwood Pharmaceuticals, Inc1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,306 in reported general payments places this provider in the 95th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$305,196
Medicare patients
565
Services billed
6,644

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide114$148,773
JardianceEmpagliflozin99$139,340
EliquisApixaban121$136,037
XareltoRivaroxaban95$134,575
OzempicSemaglutide72$118,760
FarxigaDapagliflozin Propanediol50$62,873
TrulicityDulaglutide37$57,950
ProliaDenosumab27$46,529
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$40,784
JanuviaSitagliptin Phosphate13$21,311
Soliqua 100-33Insulin Glargine/Lixisenatide22$19,297
ShingrixVaricella-Zoster Ge/As01b/Pf61$13,783
LinzessLinaclotide14$10,525
Atorvastatin Calcium919$7,723
Ezetimibe319$7,463

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,073$206,723151 claims
PfizerEliquis, Premarin$790$139,609133 claims
Boehringer IngelheimJardiance$278$139,34099 claims
Johnson & JohnsonXarelto$174$134,57595 claims
Novo NordiskOzempic$1,329$118,76072 claims
AstraZenecaFarxiga$798$62,87350 claims
GSKTrelegy Ellipta, Shingrix, Breo Ellipta$279$62,024121 claims
AmgenProlia$975$46,52927 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus$364$21,49244 claims
MerckJanuvia$199$21,31113 claims
AbbVieLinzess, Synthroid$1,029$15,36990 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$95$5,646438 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Cartersville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →